Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Teligent Pharma, Inc. | Buena, New Jersey, United States | Makes it | Serious problems, FDA actionAug 31, 2021 · 8 inspections, 1 with FDA action |
Recalls
- Jun 22, 2021 · Class III · Teligent Pharma, Inc.
Failed Impurities/Degradation Specifications
Lots: 1) NDC 52565-033-30 Lot 14010, Exp July 2021; 2) NDC 52565-033-60 Lot 13865, Exp June 2021; Lot 14011, Exp July 2021.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Erythromycin: every company that makes it
- Form
- gel
- Strength
- 20 mg per 1 g
- Approval
- ANDA ANDA208154
- On the market since
- Jul 26, 2017
- Package NDCs
52565-033-3052565-033-60- Official label
- DailyMed (National Library of Medicine), updated Jul 26, 2017
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?